Please login to the form below

Not currently logged in
Email:
Password:

KaloBios names Herb Cross as CFO

He joins from Affymax

Herb Cross is to join KaloBios as the company's new chief financial officer.

After a transition period, he will succeed Jeffrey Cooper sometime in October or November, when Cooper is set to retire to spend more time with his family.

Cross joins from biopharma company Affymax, where he was also chief financial officer.

David Pritchard, president and CEO of KaloBios, described Cross as a “well respected finance professional with over sixteen years of experience”.

"His prior work in monoclonal antibody companies and his broad leadership roles in public companies will be invaluable to KaloBios as we focus on our next stage of growth and development,” added Pritchard.

This growth is being led by three drug development programmes for therapies to treat respiratory disorders and cancer.

This includes KB001-A, which is being developed in partnership with Sanofi for the treatment of Pseudomonas aeruginosa (Pa) infections as well as by KalaBios alone as cystic fibrosis treatment.

Cross said: "KaloBios has an interesting and diverse pipeline of monoclonal antibody therapeutic candidates in clinical development, in important areas of unmet medical need.” 

23rd September 2013

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...